HIV/AIDS preventive vaccine ‘prime-boost’ phase III trial: foundations and initial lessons learned from Thailand

This publication has 17 references indexed in Scilit:

• Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand
  Vaccine, 2004
• Safety and Immunogenicity of an HIV Subtype B and E Prime‐Boost Vaccine Combination in HIV‐Negative Thai Adults
  The Journal of Infectious Diseases, 2004
• Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand
  AIDS, 2004
• Safety and Immunogenicity of Combinations of Recombinant Subtype E and B Human Immunodeficiency Virus Type 1 Envelope Glycoprotein 120 Vaccines in Healthy Thai Adults
  The Journal of Infectious Diseases, 2003
• A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
  Vaccine, 2000
• Decreasing incidence of HIV and sexually transmitted diseases in young Thai men
  AIDS, 1998
• The 100% Condom Program in Thailand
  AIDS, 1996
• Declining prevalence of HIV-1 infection in young Thai men
  AIDS, 1995
• Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand
  AIDS, 1995
• Simian Immunodeficiency Virus (mac 251-32H) Transmembrane Protein Sequence Remains Conserved Throughout the Course of Infection in Macaques
  AIDS Research and Human Retroviruses, 1993